Erratum: First-In-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01

T Toshio Shimizu J Jacob Sands (Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA) K Kiyotaka Yoh (Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan) A Alexander Spira (NEXT Oncology Virgina, Virgina Cancer Specialists Research Institute, Fairfax) E Edward B. Garon S Satoru Kitazono M Melissa L. Johnson F Funda Meric-Bernstam A Anthony W. Tolcher (NEXT Oncology, San Antonio, TX) N Noboru Yamamoto (Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo) J Jon Greenberg Y Yui Kawasaki H Hong Zebger-Gong F Fumiaki Kobayashi P Penny Phillips A Aaron E. Lisberg R Rebecca S. Heist